Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients

Diabetes

Volumn 51, Issue 3, 2002, Pages 813-818

  Nitenberg, Alain ^a,b   Ledoux, Séverine ^a   Valensi, Paul ^b   Sachs, Régis ^b   Antony, Isabelle ^a  

^a University Xavier Bichat   (France)

^b HÔPITAL JEAN VERDIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DEFEROXAMINE; OXYGEN RADICAL;

ADULT; AEROBIC METABOLISM; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY BLOOD VESSEL; CORONARY RISK; DRUG EFFECT; FEMALE; HEART MUSCLE METABOLISM; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0036317939     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.3.813     Document Type: Article

References (50)

1. Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus
2. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging
3. Diabetic cardiomyopathy
4. Diabetic cardiomyopathy
5. Evidence for cardiomyopathy in familial diabetes mellitus
6. Angina pectoris in diabetic patients with normal coronary arteries
7. Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus
8. Myocardial metabolism in type I diabetic patients without coronary artery disease
9. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta
10. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
11. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes
12. Reduced coronary NO production in conscious dogs after development of alloxan-induced diabetes
13. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors
14. 2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation
15. Vitamin C improves endothehum-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus
16. Chronic treatment in vivo with dimethylthioruea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction
17. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin
18. Standardization of the American Society of Echocardiography: Recommendations regarding quantification in M-mode echocardiography: Result of a survey of echocardiographic measurements
19. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
20. Loss of flow-dependent coronary artery dilatation in patients with hypertension
21. The iron chelator desferrioxamine attenuates postischemic ventricular dysfunction
22. Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: Evidence that myocardial "stunning" is a manifestation of reperfusion injury
23. Evidence for a role of iron-catalyzed oxidants in functional and metabolic stunning in the canine heart
24. Intracoronary papaverine: An ideal coronary vasodilator for studies of the coronary circulation in conscious humans
25. Protection against tissue damage in vivo by desferrioxamine: What is its mechanism of action
26. Effects of diabetes on metabolic coronary dilation in the rat
27. Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs
28. Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function
29. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test
30. Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man
31. Flow-induced release of endothelium derived relaxing factor
32. Effects of cardiac sympathetic innervation on coronary blood flow
33. Delineation of the distribution of β-adrenergic receptor subtypes in canine myocardium
34. Coronary vasomotion in response to sympathetic stimulation in humans: Importance of the functional integrity of the endothelium
35. Cardiac sympathetic dysinnervation in diabetes: Implications for enhanced cardiovascular risk
36. Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptor/binding proteins
37. Oxygen toxicity, oxygen radicals, transition metals and disease
38. Inactivation of endothelium-derived relaxing factor by oxidized lipoproteins
39. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta
40. Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells
41. Isoprostanes: Potential markers of oxidant stress in atherothrombotic disease
42. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus
43. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
44. Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta
45. Coronary endothelial injury after cardiopulmonary bypass and ischemic cardioplegia is mediated by oxygen-derived free radicals
46. Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts
47. The role of iron in ascorbate-dependent deoxyribose degradation: Evidence consistent with a site-specific hydroxyl radical generation caused by iron ions bound to the deoyribose molecule
48. Studies in desferrioxamine and ferrioxamine metabolism in normal and iron-loaded subjects
49. Silent coronary artery disease in diabetic patients with cardiac autonomic neuropathy
50. Autonomic dysfunction and silent myocardial ischemia on exercise testing in diabetes mellitus